The impact of PCSK9 modulation on cardiovascular outcomes: recent advances and the managed care impl...
The impact of PCSK9 modulation on cardiovascular outcomes: recent advances and the managed care implications
About this item
Full title
Author / Creator
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Cardiovascular disease (CVD) remains the leading cause of death globally. Hypercholesterolemia is a major modifiable risk factor for developing atherosclerotic CVD (ASCVD). Although statins are the foundational evidence-based treatment option, significant gaps in care exist as approximately 5% to 30% of patients do not tolerate statin therapy. Ezet...
Alternative Titles
Full title
The impact of PCSK9 modulation on cardiovascular outcomes: recent advances and the managed care implications
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2753305697
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2753305697
Other Identifiers
ISSN
1088-0224
E-ISSN
1936-2692
DOI
10.37765/ajmc.2022.89269
